Trial Profile
The effect of Lipacreon on the postoperative weight loss and the fecal consistency in patients after gastrectomy for gastric cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jul 2017
Price :
$35
*
At a glance
- Drugs Pancrelipase (Primary)
- Indications Exocrine pancreatic insufficiency
- Focus Therapeutic Use
- 13 Jul 2017 Status changed from not yet recruiting to completed.
- 09 Mar 2014 New trial record